Dysregulation of CgA-derived peptides has been reported in cardiometabolic disease 17–19, immune regulation 15,20 and Alzheimer’s disease 21, however, their mechanistic role in neurodegeneration - particularly in Tauopathies - remains largely unexplored. This evidence concerns the gene CGA and tauopathy.